BMO Capital analyst Daniel Salmon raised his price target on Criteo to $32 after a Q4 earnings beat, saying the impact of Intelligent Tracking Prevention on revenue was less severe than the management expected. Salmon adds that while his belief is that the company is compliant with E.U.'s General Data Protection Regulation, the uncertainty around any regulatory impact warrant some caution, particularly around the way that the company's clients share and collect data. The analyst keeps his Market Perform rating on Criteo, noting that shares will be constrained by regulatory overhang in the near term.